title: Wallerian degeneration involves Rho/Rho-kinase signaling.
abstract: Local axon degeneration is a common pathological feature of many neurodegenerative diseases, whereas the underlying molecular mechanisms are largely unknown. In this study, we used the degeneration of transected axons, termed "Wallerian degeneration," as a model to examine the possible involvement of Rho. Nogo-66, a myelin-derived inhibitor of axon regeneration, significantly accelerated axon degeneration of the dorsal root ganglion explant in vitro, whereas inhibiting Rho-kinase activity abolished the effect. Rho activation was observed in the distal part of the injured axons after spinal cord injury. We demonstrate that degeneration of the injured cortico-spinal axons was significantly retarded by a Rho-kinase inhibitor in vivo. Our findings suggest that inhibiting the signaling pathway may retard axon degeneration in pathological conditions.
authors.affiliation: Department of Neurobiology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
authors.forename: Satoru
authors.initials: S
authors.lastname: Yamagishi
authors.forename: Masashi
authors.initials: M
authors.lastname: Fujitani
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Hata
authors.forename: Keiko
authors.initials: K
authors.lastname: Kitajo
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Mimura
authors.forename: Hideki
authors.initials: H
authors.lastname: Abe
authors.forename: Toshihide
authors.initials: T
authors.lastname: Yamashita
mesh_terms: D000577:Amides / Q000494:pharmacology; D000818:Animals; D001369:Axons / Q000201:enzymology; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D047908:Intracellular Signaling Peptides and Proteins; D009185:Myelin Proteins / Q000494:pharmacology / Q000502:physiology; D018992:Myelin-Associated Glycoprotein / Q000502:physiology; D063308:Myelin-Oligodendrocyte Glycoprotein; D000070798:Nogo Proteins; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D015398:Signal Transduction; D013119:Spinal Cord Injuries; D014855:Wallerian Degeneration / Q000378:metabolism*; D020741:rho GTP-Binding Proteins / Q000378:metabolism*; D054460:rho-Associated Kinases
chemical_list: D000577:Amides; D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; C571328:Mog protein, rat; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein; D000070798:Nogo Proteins; D011725:Pyridines; C000603197:Rtn4 protein, rat; C108830:Y 27632; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases; D020741:rho GTP-Binding Proteins